Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Population ageing will exacerbate the burden of ageing-related diseases, including chronic kidney disease. Mitigating the effects of this burden will require coordinated, multinational efforts.
The prevalence of kidney disease and its associated morbidity and mortality continue to rise. This crisis cannot be tackled unless kidney disease is made a global public health priority.
Improved understanding of the impact of sex and gender-related factors on human health and disease and the inclusion of people of all genders in research studies is necessary to reduce health inequities and enable a more personalized approach to patient care.
June marks Pride Month — an event that aims to recognize and celebrate LGBTQ+ communities worldwide. However, it also provides an opportunity to highlight the challenges that LGBTQ+ colleagues and nephrology patients continue to face, and the need to address health inequities.
At Nature Reviews Nephrology, we believe that peer review should be a rigorous, constructive and inclusive process. We are working to meet this aim through several initiatives.
Vaccines against SARS-CoV-2 are key to ending the COVID-19 pandemic, but their success depends on global availability and acceptance, as well as measures to protect the most vulnerable.
Beyond the need to understand disease mechanisms and develop new therapies, the inequities that deprive individuals of a healthy life must also be addressed to ensure kidney health for all.
Insights into the heterogeneity of processes underlying kidney diseases and their relationship with disease phenotype could redefine classifications of disease and improve patient outcomes.
A host of innovative developments in dialysis technologies could potentially transform the field, with benefits for patient outcomes, access to therapy and environmental sustainability.
The increasing volumes of biological and clinical data have the potential to greatly enhance our understanding of the processes underlying kidney function and disease. However, maximizing outputs from these data requires a collaborative and open approach to data sharing that can only be achieved through united efforts by researchers, funders and publishers.
